Intensity Therapeutics, Inc.
USD4.10
+0.07 (+1.61%)
CEO
Lewis H. Bender
IPO Date
2023-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.96
Prev. Close
$4.04
Day Low
$3.93
Day High
$4.15
52W Low
$3.51
52W High
$43.50
Market Cap
$0.01B
Volume
0.16M
| -1.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -80.1% | -60.9% | 0.01 | 3.91 | -6.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 50.2% | -431.5% | -0.30 | 0.21 | -2.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 90.9% | -151.4% | -0.27 | 1.27 | -2.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 382.2% | -58.7% | -0.32 | 7.04 | -3.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -67.9% | -58.1% | 0.03 | 7.67 | -3.9 |
| -11.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -37.0% | -27.9% | 0.02 | 3.60 | -1.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -116.2% | -57.1% | 0.06 | 1.40 | -0.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -1002.1% | -109.2% | 0.39 | 0.63 | -2.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -109.0% | -66.5% | 0.05 | 1.92 | -2.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -126.4% | -67.4% | 0.05 | 1.63 | -3.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -93.0% | -57.3% | 0.03 | 2.32 | -3.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -47.3% | -37.1% | 0.02 | 4.43 | -3.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -24.1% | -18.3% | 0.01 | 3.91 | -9.3 |